Assessment of Response to Treatment in Patients with Otomycosis

Document Type : Original

Authors

1 Department of Otorhinolaryngology, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.

2 Student, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.

3 Department of Biostatistics, School of Medicine, Babol University of Medical Sciences, Babol, Iran.

4 Infectious Diseases & Tropical Medicine Research Center, Health Research Center, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.

Abstract

Introduction:
Due to the prevalence of otomycosis in the north of Iran, which has a humid climate, this study aimed to examine the recurrence rate of otomycosis in Iranian patients.
 Materials and Methods:
This cross-sectional study was performed in all patients suspected of otomycosis referred to the Otorhinolaryngology Clinic of Ayatollah Rouhani Hospital of Babol. Demographic and clinical data of patients as well as their symptoms were collected in a checklist at referral time and also 14 days after referral.
 Results:
The results showed that 11 (7.3%) cases had a recurrence of otomycosis. There was no significant relationship between the incidence of otomycosis and age or sex (P=0.86 and 0.88, respectively). Septate mycelium was the most observed element on direct examination. Aspergillus flavus was the most common pathogenic agent in culture media, followed by Aspergillus niger and Candida albicans.
 Conclusion:
Based on the results of this research in Babol, the recurrence of otomycosis was 7.3% and was related to swelling and erythema in ear canal.

Keywords

Main Subjects

References

1. Vennewald I, Klemm E. Otomycosis: diagnosis and treatment. Clin Dermatol. 2010;28:202–11.
2. Gharaghani M, Seifi Z, Mahmoudabadi AZ. Otomycosis in Iran: A Review. Mycopathol. 2015; 179:415–24.
3. Fasunla J, Ibekwe T, Onakoya P. Otomycosis in western Nigeria. Mycoses. 2008;51:67–70.
4. Bineshian F, Irajian G, Koochak-Alavi SK, Fredonian MR. A study on the frequency of fungal agents in otitis externa in Semnan. Iranian J Pathol. 2006; 1:141–4.
5. Gutiérrez PH, Álvarez SJ, Sanudo E, García LG-C, Sánchez CR, VallejoValdezate L. Presumed diagnosis: Otomycosis. A study of 451 patients. Acta Otorrinolaringol Esp. 2005;56:181–6.
6. Dorko E, Jenča A, Orenčák M, Viragova S, Pilipčinec E. Otomycoses of candidal origin in eastern Slovakia. Folia microbiologica. 2004; 49:601–4.
7. Kiakojuri K, Roushan MRH, Sepidgar SAA. Suction clearance and 2% topical miconazole versus the same combination with acidic drops in the treatment of otomycosis. Southeast Asian J Trop Med Public Health. 2007;38:749–53.
8. Kombila M, Gomez dDM, De Bievre C, Crepet G, Debrie J, Belembaogo E, et al. Fungal otitis in Libreville. Study of 83 cases. Bull Soc Pathol Exot Filiales.1988;82:201–7.
9. Jung T, Jin T. Diseases of the external ear. In: Ballenger’s otorhinolaryngology head and neck surgery. 6th ed. Spain: BC Decker; 2003.
10. Mishra G, Mehta N, Pal M. Chronic bilateral otomycosis caused by Aspergillus niger. Mycoses. 2004;47:82–4.
11. Prasad SC, Kotigadde S, Shekhar M, Thada ND, Prabhu P, D’Souza T, et al. Primary otomycosis in the Indian subcontinent: predisposing factors, microbiology, and classification. Int J Microbiol. 2014;2014: 636493.
12. Barati B, Okhovvat S, Goljanian A, Omrani M. Otomycosis in central Iran: a clinical and mycological study. Iranian Red Cres Med J. 2011; 2011:873–6.
13. Zarei Mahmoudabadi A, Abshirini H, Rahimi R. Fungal flora of hearing aid moulds and ear canal in hearing aid wearers in school children in Ahvaz, Iran (2008). Jundishapur J Microbiol. 2009;2:22–4.
14. Munguia R, Daniel SJ. Ototopical antifungals and otomycosis: a review. Int J Pediatr Otorhinolaryngol. 2008;72:453–9.
15. Anwar K, Gohar MS. Otomycosis; clinical features, predisposing factors and treatment implications. Pakistan J Med Sci. 2014;30:564.
16. Jia X, Liang Q, Chi F, Cao W. Otomycosis in Shanghai: aetiology, clinical features and therapy. Mycoses. 2012;55:404–9.
17. Ho T, Vrabec JT, Yoo D, Coker NJ. Otomycosis: clinical features and treatment implications. Otolaryngol Head Neck Surg. 2006; 135:787–91.
18. Sagit M, Somdas MA, Korkmaz F, Akcadag A. The ototoxic effect of intratympanic terbinafine applied in the middle ear of rats. J Otolaryngol Head Neck Surg. 2013;42:13.
19. Alnawaiseh S, Almomani O, Alassaf S, Elessis A, Shawakfeh N, Altubeshi K, et al. Treatment of otomycosis: a comparative study using miconazole cream with clotrimazole otic drops. JRMS. 2011; 18:34–7.
20. Berjis N, Okhovat SA, Koujani ZS, Baradaran S. Comparing the Therapeutic Effect of Clotrimazole and Tolnaftate in Treating Variety of Fungal Species Producing Otomycosis in Alzahra and Kashani Hospitals, Iran J Isfahan Medl School. 2012;29(164).
21. Salamat AA, Archer C, Basarab A, Eren E, Batty V, Patel S, et al. Scedosporium apiospermum causing otomycosis in an immunocompetent child with tympanostomy tubes: Management of this rare entity. Int J Pediatr Otorhinolaryngol. 2015; 79: 1785–7.
22. Afshari MA, Kachoui R, Ajalloveyan M. Assessment of Prevalence of Otomycosis in ENT Clinic in Baqiyatallah (a.s.) Hospital. Journal of Military Medicine. 2005;7:121–4.
23. Kiakojori K, Nazari M, Rajabnia R, Khafri S, Mahdavi Omran S. The Evaluation of the Causes of Otitis Externa in Children referring to the ENT Clinic of Ayatollah Rohani Hospital of Babol, 2013–14. J Babol Uni Med Sci. 2015;17:25–30.
24. Nemati S, Hassanzadeh R, Jahromi SK, Abadi ADN. Otomycosis in the north of Iran: common pathogens and resistance to antifungal agents. Eur Arch OtoRhinoLaryngol. 2014;271:953–7.
25. Kiakojuri K, Rajabnia R, Jalili B, Khafri S, Omran SM. Otomycosis in Adolescent Patients Referred to the Therapeutic Centers in Babol City, Iran. Jundishapur J Microbiol. 2015;8(5).
26. García-Agudo L, Aznar-Marín P, Galán-Sánchez F, García-Martos P, Marín-Casanova P, Rodríguez-Iglesias M. Otomycosis due to filamentous fungi. Mycopathologia. 2011;172: 307–10.
27. Loh K, Tan K, Kumarasinghe G, Leong H, Yeoh K. Otitis externa--the clinical pattern in a tertiary institution in Singapore. Ann Acad Med, Singapore. 1998;27:215–8.
28. Kazemi AH, Nejadkazem M. Evaluation of otomycosis in east azerbaijan. Med J Mashhad Uni Med Sci. 2009;52:233–8.
29. Beaney G, Broughton A. Tropical otomycosis. J Laryngol Otol. 1967;81):987–97.
30. Kaur R, Mittal N, Kakkar M, Aggarwal AK, Mathur MD. Otomycosis: a clinicomycologic study. ENT J. 2000;79(8):606.
31. Abou-halawa AS, Khan M, Alrobaee A, Alzolibani A, Alshobaili H. Otomycosis with perforated tympanic membrane: self medication with topical antifungal solution versus medicated ear wick. Int J Health Sci. 2012;6(1).
32. Ozcan M, Ozcan MK, Karaarslan A, Karaarslan F. Concomitant otomycosis and dermatomycoses: a clinical and microbiological study. Eur Archives Otorhinolaryngology. 2003;260:24–7.
 
 
Iranian Journal of Otorhinolaryngology
Volume 30, Issue 1
January and February 2018
Pages 41-47

Files

Share

How to cite

Statistics